BSX Boston Scientific Corp

  1. Stocks
  2. Healthcare
  3. NYSE: BSX

Price (delayed)

$48.83

Market cap

$70.06B

P/E Ratio

108.51

Dividend/share

N/A

EPS

$0.45

Enterprise value

$78.07B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, ...

Highlights
The revenue has increased by 7% YoY
Boston Scientific's gross profit has increased by 7% YoY
The EPS has decreased by 35% YoY but it has increased by 10% from the previous quarter
Boston Scientific's net income has decreased by 33% YoY but it has increased by 7% QoQ
The P/E is 35% above the 5-year quarterly average of 80.6 and 25% above the last 4 quarters average of 87.0
Boston Scientific's debt has increased by 4.1% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: https://www.bostonscientific.com/
Peers: EW SYK MMSI MDT

Key stats

What are the main financial stats of BSX
Market
Shares outstanding
1.43B
Market cap
$70.06B
Enterprise value
$78.07B
Valuations
Price to earnings (P/E)
108.51
Price to book (P/B)
3.98
Price to sales (P/S)
5.51
EV/EBIT
48.49
EV/EBITDA
28.43
EV/Sales
6.16
Earnings
Revenue
$12.68B
EBIT
$1.61B
EBITDA
$2.75B
Free cash flow
$1.02B
Per share
EPS
$0.45
Free cash flow per share
$0.71
Book value per share
$12.27
Revenue per share
$8.87
TBVPS
$9.54
Balance sheet
Total assets
$32.47B
Total liabilities
$14.9B
Debt
$8.94B
Equity
$17.57B
Working capital
$1.96B
Liquidity
Debt to equity
0.51
Current ratio
1.51
Quick ratio
0.76
Net debt/EBITDA
2.92
Margins
EBITDA margin
21.7%
Gross margin
68.8%
Net margin
5.5%
Operating margin
13%
Efficiency
Return on assets
2%
Return on equity
3.7%
Return on invested capital
9.1%
Return on capital employed
5.6%
Return on sales
12.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
1.84%
1 week
2.58%
1 month
4.92%
1 year
10.43%
YTD
5.53%
QTD
5.53%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$12.68B
Gross profit
$8.73B
Operating income
$1.65B
Net income
$697M
Gross margin
68.8%
Net margin
5.5%
Boston Scientific's net margin has decreased by 37% YoY but it has increased by 6% QoQ
Boston Scientific's operating income has increased by 37% YoY and by 12% from the previous quarter
Boston Scientific's net income has decreased by 33% YoY but it has increased by 7% QoQ
BSX's operating margin is up by 29% year-on-year and by 11% since the previous quarter

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
P/E
108.51
P/B
3.98
P/S
5.51
EV/EBIT
48.49
EV/EBITDA
28.43
EV/Sales
6.16
The EPS has decreased by 35% YoY but it has increased by 10% from the previous quarter
The P/E is 35% above the 5-year quarterly average of 80.6 and 25% above the last 4 quarters average of 87.0
The stock's price to book (P/B) is 17% more than its last 4 quarters average of 3.4 but 10% less than its 5-year quarterly average of 4.4
The equity has grown by 6% YoY
BSX's P/S is 15% above its last 4 quarters average of 4.8 and 8% above its 5-year quarterly average of 5.1
The revenue has increased by 7% YoY

Efficiency

How efficient is Boston Scientific business performance
The return on equity has declined by 39% year-on-year but it has increased by 6% since the previous quarter
The return on assets has declined by 35% year-on-year but it has grown by 5% since the previous quarter
The ROS has increased by 18% from the previous quarter and by 7% YoY
BSX's ROIC is up by 17% from the previous quarter and by 10% YoY

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 118% more than its total liabilities
BSX's quick ratio is up by 23% since the previous quarter but it is down by 13% year-on-year
BSX's total liabilities is down by 4.6% year-on-year but it is up by 4.1% since the previous quarter
Boston Scientific's debt is 49% lower than its equity
Boston Scientific's debt to equity has decreased by 7% YoY but it has increased by 4.1% from the previous quarter
The equity has grown by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.